Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic Impact of Next-Generation Sequencing Panels for Lymphoproliferative Neoplasms on Small-Volume Biopsies.

American journal of clinical pathology - 2 Sept 2022

Fei Fei, Natkunam Yasodha, Zehnder James L, Stehr Henning, Gratzinger Dita

Abstract excerpt

OBJECTIVES: We investigated the feasibility and utility of next-generation sequencing (NGS)-based targeted somatic mutation panels and IG/TR gene rearrangement assays in the diagnosis of lymphoproliferative disorders (LPDs) in small-volume biopsies. MATERIALS: We performed a retrospective, single-institution review of all NGS assays requested over a 3-year period by hematopathologists for diagnostic purposes on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Gene Rearrangement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 35552630
DOI: 10.1093/ajcp/aqac045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Impact of Next-Generation Sequencing Panels for Lymphoproliferative Neoplasms on Small-Volume Biopsies.PMID 35552630Read ↗

Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders.Semantic proximity Read ↗

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.Semantic proximity Read ↗

Next-generation sequencing for lymphoid neoplasms: Real-world utility from a clinical assay.Semantic proximity Read ↗

Impact of next generation sequencing results on clinical management in patients with hematological disorders.Semantic proximity Read ↗

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma.Semantic proximity Read ↗

[Routine high-throughput targeted sequencing of lymphoproliferative diseases : Clinical utility and challenges].Semantic proximity Read ↗

Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.Semantic proximity Read ↗

Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience.Semantic proximity Read ↗

Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group reportSemantic proximity Read ↗

Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsSemantic proximity Read ↗

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.Semantic proximity Read ↗

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.